Allstate Corp Veracyte, Inc. Transaction History

Allstate Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$21.94 - $42.51 $178,416 - $345,691	-8,132 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$36.09 - $53.79 $7,867 - $11,726	-218 Reduced 2.61%	8,132 $335,000
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $59,805 - $88,936	1,679 Added 25.17%	8,350 $388,000
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $219,742 - $377,712	6,671 New	6,671 $267,000
Q1 2021 May 14, 2021	SELL	$44.47 - $81.38 $264,107 - $483,315	-5,939 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$32.49 - $61.88 $32,425 - $61,756	-998 Reduced 14.39%	5,939 $291,000
Q3 2020 Nov 13, 2020	BUY	$26.73 - $35.67 $185,426 - $247,442	6,937 New	6,937 $225,000

307

81.7M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.93B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.